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Abstract
Background: Ethanol extract from Gynostemma pentaphyllum (GP) shows anti-stress and anxiolytic functions in
mice, and also protects dopamine neurons in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. In
addition, gypenosides (the gypenoside-enriched components of GP, GPS) have a protective effect on 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. In this study, the ameliorating effects of GPS on
chronic stress-induced anxiety disorders in mice were investigated.
Methods: Mice were orally treated with GPS (100 and 200 mg/kg) once a day for 10 days, followed by exposure to
electric footshock (EF) stress (0.6 mA, 1 s every 5 s, 3 min). After the final administration of either GPS, water extract of
GP (GP-WX) or ethanol extract of GP (GP-EX, positive control), the behavioral tests such as elevated plus-maze, marble
burying and locomotor activity tests, and the biochemical parameters including dopamine, serotonin and corticosterone
levels, and c-Fos expression were examined.
Results: Treatment with GPS (100 and 200 mg/kg) increased the number of open arm entries and the time spent on
open arms in elevated plus-maze which were reduced by chronic EF stress. GPS (100 and 200 mg/kg) reduced the
number of marbles buried which increased by chronic EF stress. In these states, the brain levels of dopamine and
serotonin decreased by chronic EF stress and they were recovered by GPS. The serum levels of corticosterone increased
by chronic EF stress were also reduced by GPS (100 and 200 mg/kg). Finally, chronic EF stress-induced c-Fos expression
was markedly reduced by GPS (100 and 200 mg/kg) in the brain. GPS (100 and 200 mg/kg) also showed an equivalent
efficacy on anxiolytic functions, as compared with GP-EX (50 mg/kg). However, GP-WX (50 mg/kg) showed a less effect
on anxiety disorders than GP-EX (50 mg/kg) and GPS (100 and 200 mg/kg).
Conclusion: These results suggest that GPS (100 and 200 mg/kg) has anxiolytic effects on chronic EF stress-induced
anxiety disorders by modulating dopamine and serotonin neuronal activities, c-Fos expression and corticosterone levels.
GPS may serve as a phytonutrient in chronic stress-induced anxiety disorders.
Keywords: Gypenosides, Chronic stress-induced anxiety disorders, Elevated plus-maze, Dopamine, Serotonin,
Corticosterone
Background
Slight or acute stress and repeated long-lasting or chronic
stress are characterized by the physiological changes that
occur in response to novel or threatening stimuli. Chronic
stress has been linked to the pathophysiology of various
psychiatric disorders, including anxiety disorders and de-
pression [1]. In the conditions of chronic stress-induced
anxiety disorders and depression, the levels of dopamine
and serotonin in the brain are decreased. In contrast, the
serum levels of glucocorticoids such as corticosterone and
cortisol are increased by various chronic stresses, and this
is mediated by the hypothalamic-pituitary-adrenal axis [2].
In addition, c-Fos protein, which is an immediate early
gene, is stimulated against chronic stress in various brain
regions of mice and rats, especially paraventricular nuclei
(PVN) of hypothalamus [3, 4].
A number of chronic stress models, including electric
footshock (EF) stress, forced swimming, noise stimuli and
immobilization have been employed to induce anxiety
disorders [5, 6]. In the field of anxiety disorders induced
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by chronic stress, the elevated plus-maze and marble
burying tests are widely used in response to threa-
tening stimuli [7, 8]. Spontaneous locomotor activity can
be also decreased by chronic stress [9].
The traditional medicinal herb, Gynostemma pentaphyl-
lum Makino (GP, Cucurbitaceae) has been identified with
about 90 dammarane-type glycoside derivatives (called
Gynostemma total saponins, gypenosides or gynosapo-
nins) and flavonoids [10]. Previously, ethanol extract from
GP (GP-EX) has been reported to have anti-stress and
anxiolytic functions in mice [6]. GP-EX also protects dopa-
mine neurons in 6-hydroxydopamine-lesioned rat model of
Parkinson’s disease (PD) [11]. In addition, the gypenoside-
enriched components (gypenosides, GPS) have a protective
effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-in-
duced mouse model of PD [12, 13].
In this study, in order to further define the anxiolytic
function of GP, the pharmacological effects of GPS, which
was obtained from GP [12, 13], on chronic electric foot-
shock (EF) stress-induced anxiety disorders in mice were
investigated. In addition, the anxiolytic functions by GPS
were compared with those by water extract of GP (GP-
WX) and GP-EX (positive control).
Methods
Chemicals
Dopamine, norepinephrine, serotonin and 5-hydro
xyindoleacetic acid (HIAA) were purchased from
Sigma (St Louis, MO, USA). Corticosterone kit was ob-
tained from USCN Life Sci. (E0504 m, Wuhan, China)
and c-Fos antibody was from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). All other chemicals were of ana-
lytical grade.
Preparation of GPS and GP extract
GPS were purchased from Ankang Dongke Maidisen Co.
(purity > 98 %, determined by UV) (Xi’an, China) [12, 13].
GP was obtained from Wonkwang Food Manufacturing
Co. (Geochang, Korea) and a voucher specimen of the
herbal leaves of GP was deposited at the herbarium of the
College of Pharmacy, Chungbuk National University
(Cheongju, Korea). The air-dried leaves of GP (5 kg) were
extracted twice with distilled water at 80 °C for 3 h (GP-
WX) and 80 % ethanol at 25 °C for 12 h (GP-EX), respect-
ively, and then the each extract was evaporated to dryness
[6, 10, 14]. Ultimately, 390 g (7.8 %, w/w) of GP-WX and
490 g (9.8 %, w/w) of GP-EX, which were determined
using high performance liquid chromatography (HPLC),
were obtained.
Experimental design
Mice (ICR, male, 20–25 g) were obtained from Samtako
Co. (Osan, Korea). Mice were housed two per cage in a
temperature and humidity controlled environment (12-h
light/dark cycle, 23 ± 2 °C, 60 ± 2 %), with ad libitum ac-
cess to standard mouse food and water. This study was
approved by the Animal Ethics Committee of Chungbuk
National University (Approval No., CBNU-481-12-01).
The experiment was performed by 2 separate subsets
for the elevated plus-maze and marble burying tests in-
cluding the biochemical analyses, and for the spontaneous
locomotor activity test including the immunohistochemi-
cal analyses. Each subset contained 16 groups (8–10 ani-
mals per group): half groups were exposed to the chronic
EF stress and half were not. Each eight groups were orally
treated for 10 days before 4 h the exposure of EF stress as
follow: control group was the group that received saline
(0.9 %), each GPS-treated group was the group that re-
ceived one of the different doses of GPS (30, 50, 100, 200,
or 400 mg/kg), GP-WX treated group was the group that
received GP-WX (50 mg/kg), and GP-EX-treated group
was the group that received GP-EX (50 mg/kg). Stress was
the group which was exposed to chronic EF stimuli with
either saline (0.9 %), GPS, GP-WX or GP-EX for 10 days.
GP-EX was used as a positive control [6].
In the first experiments, the elevated plus-maze and
marble burying tests were performed on the final day
(day-10) at 30 min after the exposure of EF stress. The
elevated plus maze test was carried out before the mar-
ble burying test to approximate a stressor (the interval
time, 15–20 min) [15]. After the behavioral tests, the mice
were sacrificed to obtain brain tissues and serum for bio-
chemical analyses. In the second experiments, the spon-
taneous locomotor activity test was carried out every day
after 30 min of the exposure of chronic EF stress and then,
the mice were also sacrificed to obtain brain tissues for
immunehistochemical analyses.
The exposure of chronic EF stress
The mice were placed individually in the electrified shock
chamber for the exposure to chronic stress and they re-
ceived unavoidable EF stimuli (intensity, 0.6 mA, 1 s every
5 s, periods, 3 min) at 14:00 every day for 10 days using
an electric shock generator (Seil Electric Co., Taejeon,
Korea) [16].
The elevated plus-maze test
The elevated plus-maze apparatus consists of four arms:
two open arms (30 × 5 cm) and two closed arms of the
same size, with 16-cm-high black walls elevated 45 cm
above the floor. The open and closed arms were con-
nected via a central square (5 × 5 cm) to form a plus
sign. The 5-min pre-adaptation period of 1 time for the
last 3-days was conducted before the main test [17]. The
number of open arm entries and the time spent on the
open arms were recorded during a 5-min test period
after the adaptation period of 5-min by a video camera
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connected to a SMART video-tracking system (Panlab
S.I., Barcelona, Spain) [7].
The marble burying test
The marble burying test was placed in a cage measur-
ing 33 cm × 21 cm × 19 cm (l × w × h), containing bed-
ding that was 5 cm in depth, with twenty marbles in
a 4 × 5 arrangement along the same short wall of the
cage. The 15-min pre-adaptation period for the last
3-days was applied before the main test [18]. Testing
was conducted for a 30-min period under red light
and white noise. After a 30 min, the number of mar-
bles buried was recorded and marbles were consid-
ered to be buried if at least two thirds of their
surface was covered with bedding [8].
The spontaneous locomotor activity test
The locomotor activity was determined by a tilting-type
ambulometer (Model AMB-10, O’Hara, Tokyo, Japan).
Each mouse was placed in the round activity cage (20 cm
in diameter and 18 cm in depth) and after an adaptation
period of 10 min, the counts of horizontal move-
ments of mice inside the cage were automatically re-
corded in 30 min [6].
Measurement of dopamine, serotonin and
corticosterone levels
The whole brains were dissected out and frozen in a −70 °C
until analysis. For the measurement of dopamine levels, the
brain tissues were homogenized in perchloric acid (300 μL,
1 M) and isoproterenol (100 pmol, internal standard),
and dopamine levels were measured by an HPLC sys-
tem [19]. For the measurement of serotonin levels, the
brain tissues were also homogenized in trichloroacetic
acid (500 μL, 0.3 M) and HIAA (300 pmol, internal
standard), and serotonin levels were measured by an
HPLC system [6].
Blood was collected from the heart of sacrificed mice,
and was then centrifuged to obtain a serum. Cortico-
sterone levels were assessed using an enzyme-linked
immunosorbent assay kit [6].
Immunohistochemistry of c-Fos
Mice were transcardially perfused with a paraformalde-
hyde solution (4 % in 0.1 M phosphate buffered saline,
pH 7.4), and then the brains were removed. Coronal
sections (35 μm) at the PVN regions were processed for
c-Fos immunocytochemistry using a polyclonal rabbit
anti-c-Fos antibody (1:500) and a biotinylated goat anti-
rabbit antibody (1:1,000; Vector Laboratories, Burlingame,
CA). The sections were incubated in avidin:biotinylated
enzyme complex kit and exposed to 3,3′-diaminobenzidine
kit for detection. c-Fos-positive cells in the PVN regions
were counted using an image analysis system (Axiovision
software, Carl Zeiss MicroImaging, GmbH, Jena, Germany)
using a microscope (100X magnification) (Zeiss Axiophot,
Carl Zeiss MicroImaging).
Statistical analysis
Data were analyzed with one-way analysis of variance
(ANOVA) followed by Tukey’s test for evaluating the dose-
dependent effects, two-way ANOVA followed by Tukey’s
test for evaluating the effects on chronic stress and three-
way ANOVA by Tukey’s test for evaluating the effect on
between the three factors, doses, un-stressed and stressed
stimuli, and days. All data represented as means ±
S.E.M. with p values < 0.05 being considered statisti-
cally significant.
Results
Effects of GPS on elevated plus-maze
In the un-stressed groups, treatment with GPS (30, 50, 100,
200 and 400 mg/kg) once a day for 10 days did not alter
both the number of open arm entries and the time spent
on open arms in the elevated plus-maze test, compared
with control group (Fig. 1). In contrast, the number of open
arm entries and the time spent on open arms showed the
significant differences between the un-stressed groups and
stressed groups ((A) F = 9.411, (B) F = 16.352; p < 0.05)
(Fig. 1). The number of open arm entries and the time
spent on open arms also decreased by 31.5 % (p < 0.01) and
48.4 % (p < 0.01) by chronic EF stress, compared with con-
trol group (Fig. 1a and b). However, the number of open
arm entries increased by 19.6 % (p < 0.05) and 18.6 %
(p < 0.05), respectively by treatment with GPS (100 and
200 mg/kg) for 10 days, compared with chronic EF-stressed
group (Fig. 1a). However, GPS (30, 50 and 400 mg/kg) did
not show significant effects (7.4 %, 12.0 % and 12.7 %;
p > 0.05) (Fig. 1a). The times spent on open arms
reduced by chronic EF stress also increased by 20.4 %
(p < 0.05) and 18.1 % (p < 0.05), respectively by treat-
ment with GPS (100 and 200 mg/kg), compared with
chronic EF-stressed group (Fig. 1b). However, GPS
(30, 50 and 400 mg/kg) did not show significant effects
(10.3 %, 14.2 % and 16.5 %; p > 0.05) (Fig. 1b).
The number of open arm entries and the time spent on
open arms, which decreased by chronic EF stress, were
also recovered by 18.8 % (p < 0.05) and 21.1 % (p < 0.05),
respectively by treatment with GP-WX (50 mg/kg) for
10 days, compared with chronic EF-stressed group
(Fig. 1a and b).
Effects of GPS on marble burying
In the un-stressed groups, treatment with GPS (30–
400 mg/kg, 10 days) had no effect on the number of mar-
bles buried. The number of marbles buried increased by
60.2 % (p < 0.01) by exposure to chronic EF stress, com-
pared with control group (Fig. 2). However, the number of
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Fig. 1 Effects of GPS on the number of open arm entries (a) and time spent on open arms (b) in the elevated plus-maze test in mice. Mice (ICR, male,
25–30 g) were orally treated with GPS (30, 50, 100, 200 and 400 mg/kg), GP-WX (50 mg/kg), GP-EX (50 mg/kg, positive control) or saline (0.9 %) once a
day for 10 days. Mice were exposed to EF stimuli (intensity, 0.6 mA, 1 s every 5 s, periods, 3 min) for chronic stress for 10 days (chronic EF-stressed groups,
Stress). The elevated plus-maze test was performed as described under the Methods section. The results are expressed as means ± S.E.M. for 8–10 animals
per group. **p< 0.01 compared with control group; #p< 0.05 compared with chronic EF-stressed group (one-way ANOVA followed by Tukey’s
test); §p < 0.05 compared with between the un-stressed groups and stressed groups (two-way ANOVA followed by Tukey’s test)
Fig. 2 Effects of GPS on the number of marbles buried in the marble burying test in mice. Mice (ICR, male, 25–30 g) were orally treated with GPS
(30, 50, 100, 200 and 400 mg/kg), GP-WX (50 mg/kg), GP-EX (50 mg/kg, positive control) or saline (0.9 %) once a day for 10 days. Mice were also
exposed to EF stimuli (intensity, 0.6 mA, 1 s every 5 s, periods, 3 min) for chronic stress for 10 days (chronic EF-stressed groups, Stress). The marble
burying test was performed as described under the Methods section. The results are expressed as means ± S.E.M. for 8–10 animals per group. **p < 0.01
compared with control group; #p < 0.05, ##p < 0.01 compared with chronic EF-stressed group (one-way ANOVA followed by Tukey’s test); §p < 0.05
compared with between the un-stressed groups and stressed groups (two-way ANOVA followed by Tukey’s test)
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marbles buried of the stressed groups showed the signifi-
cant differences between the un-stressed groups and
stressed groups (F = 5.284, p < 0.05) (Fig. 2). The number
of marbles buried also decreased by 31.3 % (p < 0.01),
25.2 % (p < 0.05) and 24.9 % (p < 0.05), respectively by
treatment with GPS (100, 200 and 400 mg/kg) for 10 days,
compared with chronic EF-stressed group (Fig. 2). How-
ever, GPS (30 and 50 mg/kg) did not show significant
effects (6.2 % and 12.4 %; p > 0.05) (Fig. 2).
In addition, the number of marbles buried decreased by
25.1 % (p < 0.05) by treatment with GP-WX (50 mg/kg),
compared with chronic EF-stressed group (Fig. 2).
Effects of GPS on spontaneous locomotor activity
In the un-stressed groups, treatment with GPS (30–
400 mg/kg, 10 days) exhibited no significant effect on
the spontaneous locomotor activity. The spontaneous
locomotor activities showed the significant differences
between the un-stressed groups and stressed groups
(stress treated with saline and stress treated with GPS 100,
200, 400 mg/kg) (F = 2.469, p < 0.05). GPS (100 mg/kg) was
shown as a representative (Fig. 3). The spontaneous
locomotor activities also showed a significant three-way
interaction between factors, doses, un-stressed and
stressed stimuli, and days (day-1 and day-10) (F = 2.041,
p < 0.05) (Fig. 3).
In the stressed groups, the spontaneous locomotor ac-
tivities showed biphasic results. The spontaneous loco-
motor activities by exposure to acute EF stress for 2–4
days increased by 16.8 % (p < 0.05) (Fig. 3), compared with
control group and baseline. However, after exposure to
chronic EF stress for 10 days, spontaneous locomotor ac-
tivity decreased by 18.1 % (p < 0.05), compared with con-
trol group, which was increased 15.4 (p < 0.05) and 15.8 %
(p < 0.05), respectively by GPS (100 and 200 mg/kg), com-
pared with chronic EF-stressed group (Fig. 3). However,
GPS (30, 50 and 400 mg/kg) did not show significant ef-
fects (8.7 %, 9.4 % and 12.8 %; p > 0.05) (Fig. 3).
Treatment with GP-WX (50 mg/kg) also increased
spontaneous locomotor activity by 15.0 % (p > 0.05), com-
pared with chronic EF-stressed group (Fig. 3).
Effects of GPS on the levels of dopamine and serotonin in
the brain
In the un-stressed groups, treatment with GPS (30–
400 mg/kg) for 10 days did not alter the levels of dopamine
Fig. 3 Effects of GPS on spontaneous locomotor activity after exposure to chronic EF stress in mice. Mice (ICR, male, 25–30 g) were orally treated
with GPS (30, 50, 100, 200 and 400 mg/kg), GP-WX (50 mg/kg), GP-EX (50 mg/kg, positive control) or saline (0.9 %) once a day for 10 days. Mice
were also exposed to EF (intensity, 0.6 mA, 1 s every 5 s, periods, 3 min) for chronic stress for 10 days (chronic EF-stressed groups, Stress). Spontaneous
locomotor activity was performed as described under the Methods section. The results are expressed as means ± S.E.M. for 8–10 animals per groups.
*p < 0.05 compared with control group at each day; #p < 0.05 compared with chronic EF-stressed group at each day); †p < 0.05 compared with baseline
(one-way ANOVA followed by Tukey’s test); §p < 0.05 compared with between the un-stressed groups and stressed groups (two-way ANOVA followed
by Tukey’s test); Φp < 0.05 compared with day-1 group between the three factors, doses, un-stressed and stressed stimuli, and days (three-way ANOVA
followed by Tukey’s test)
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and serotonin in the brain, compared with control group
(GPS at 100 mg/kg was shown as a representative) (Table 1).
Dopamine levels significantly decreased by 26.6 % (p < 0.05)
after being exposed to EF stress for 10 days, compared with
control group, and they increased by 18.0 % (p < 0.05) and
16.6 % (p < 0.05), respectively by treatment with GPS (100
and 200 mg/kg), compared with chronic EF-stressed
group (Table 1). However, GPS (30, 50 and 400 mg/kg)
did not show significant effects (8.4 %, 11.4 % and 11.9 %;
p > 0.05) (Table 1). The levels of dopamine (F = 6.233,
p < 0.05) and serotonin (F = 8.865, p < 0.05) of the stressed
groups also showed the significant differences between the
un-stressed groups and stressed groups (Table 1). In
addition, dopamine levels increased by 19.1 % (p < 0.05)
by GP-WX (50 mg/kg), compared with chronic EF-
stressed group (Table 1).
Serotonin levels also decreased by 25.1 % (p < 0.05) by
chronic EF stress, compared with control group (Table 1).
However, serotonin levels were reduced by chronic EF
stress increased by 17.6 % (p < 0.05) and 15.7 % (p < 0.05),
respectively by treatment with GPS (100 and 200 mg/kg),
compared with chronic EF-stressed group (Table 1).
However, GPS (30, 50 and 400 mg/kg) did not show sig-
nificant effects (6.3 %, 9.1 % and 10.5 %; p > 0.05) (Table 1).
In addition, serotonin levels increased by 16.1 % (p < 0.05)
by treatment with GP-WX (50 mg/kg), compared with
chronic EF-stressed group (Table 1).
Effects of GPS on the levels of corticosterone in the serum
In the un-stressed groups, the levels of corticosterone in
the serum were not altered by treatment with GPS (30–
400 mg/kg) for 10 days, compared with control group
(GPS at 100 mg/kg was shown as a representative) (Table 1).
Corticosterone levels increased by 26.3 % (p < 0.05) by
exposure to chronic EF stress for 10 days, compared with
control group (Table 1). The levels of corticosterone also
showed the significant differences between the un-stressed
groups and stressed groups (F = 3.454, p < 0.05) (Table 1).
However, corticosterone levels decreased by 16.1 %
(p < 0.05) and 15.8 % (p < 0.05), respectively by treatment
with GPS (100 and 200 mg/kg) for 10 days, compared
with chronic EF-stressed group (Table 1). However, GPS
(30, 50 and 400 mg/kg) did not show significant effects
(6.1 %, 8.4 % and 14.1 %; p > 0.05) (Table 1).
Table 1 Effects of GPS on the levels of dopamine, serotonin and corticosterone
Mice (ICR, male, 20–25 g) were orally treated with GPS (30–400 mg/kg), GP-WX (50 mg/kg), GP-EX (50 mg/kg, positive control) or saline (0.9 %) once a day for
10 days. Mice were also exposed to EF stimuli (intensity, 0.6 mA, 1 s every 5 s, periods, 3 min) for chronic stress for 10 days (chronic EF-stressed group, Stress). The
brains were removed, and the levels of dopamine and serotonin in brain were determined by an HPLC method. The blood samples were collected on the last day of
the behavioral tests, and the levels of corticosterone in serum were determined by an enzyme-linked immunosorbent assay kit. GPS (100 mg/kg) was shown as a
representative of the un-stressed groups. The results are expressed as means ± S.E.M. for 8–10 animals per group. *p < 0.05 compared with control group; #p < 0.05
compared with chronic EF-stressed group (Stress) (one-way ANOVA followed by Tukey’s test). §p < 0.05 compared with between the un-stressed groups and stressed
groups (two-way ANOVA followed by Tukey’s test)
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The levels of corticosterone were also reduced by 15.0 %
(p < 0.05) by treatment with GP-WX (50 mg/kg), com-
pared with chronic EF-stressed group (Table 1).
Effects of GPS on c-Fos-immunoreactive cells in the PVN
GPS (30–400 mg/kg) for 10 days did not alter the expres-
sion of c-Fos (GPS at 100 mg/kg was shown as a represen-
tative) (Fig. 4). The expression of c-Fos protein in the PVN
markedly increased to 188 % (p < 0.01) by exposure to
chronic EF stress for 10 days, compared with control group
(Fig. 4a and b). However, c-Fos expression was reduced by
treatment with GPS (50–400 mg/kg) for 10 days in the
PVN (Fig. 4a). The number of c-Fos-immunoreactive cells
in the PVN, which increased by chronic EF stress, sig-
nificantly decreased by 19.4 % (p < 0.05), 23.6 (p <0.05),
30.2 % (p < 0.01), 24.3 % (p < 0.05) and 24.0 % (p < 0.05),
respectively by treatment with GPS (30, 50, 100, 200 and
400 mg/kg), compared with chronic EF-stressed group
(Fig. 4b). c-Fos expression of the stressed groups also
significantly increased compared with the un-stressed groups
(F = 23.192, p < 0.05) (Fig. 4b).
In addition, cFos expression was reduced by treatment
with GP-WX (50 mg/kg) for 10 days in the PVN (Fig. 4a)
and the increased number of c-Fos-immunoreactive cells
by chronic EF stress was significantly reduced by 28.7 %
(p < 0.05) by treatment with GP-WX (50 mg/kg), com-
pared with chronic EF-stressed group (Fig. 4b).
Discussion
Chronic stress-induced anxiety disorders are currently
one of the most important public health concerns. Re-
cently, GP-EX has been reported to have an ameliorating
effect on chronic EF stress-induced anxiety disorders
through the elevated plus-maze and marble burying tests in
mice [6]. In this study, the anxiolytic effects of the
gypenoside-enriched components, GPS, and GP-WX on
chronic EF stress-induced anxiety disorders were investi-
gated. In addition, their anxiolytic functions were compared
Fig. 4 Representative photographs illustrating the effects of GPS on c-Fos-immunoreactive cells in the PVN (a) and the number of c-Fos-immunoreactive
cells in the PVN (b). Mice (ICR, male, 25–30 g) were orally treated with GPS (30, 50, 100, 200 and 400 mg/kg), GP-WX (50 mg/kg), GP-EX (50 mg/kg, positive
control) or saline (0.9 %) once a day for 10 days. Mice were also exposed to EF stimuli (intensity, 0.6 mA, 1 s every 5 s, periods, 3 min) for chronic stress for
10 days. GPS (100 mg/kg) was shown as a representative of the un-stressed groups. a Immunoblots of lysates from the brain were probed with
c-Fos antibodies, and the total c-Fos-immunoreactive cells were measured as described under the Methods section. The arrow indicates
nucleus of c-Fos-positive neurons. Scale bar is 100 μm. b The number of c-Fos-immunoreactive cells was counted in the PVN and was
expressed as a percentage of the control groups. The number of c-Fos-immunoreactive cells of the control groups was 24 ± 4 cells per
section. The results are expressed as means ± S.E.M. for 8 animals per group. **p < 0.01 compared with control group; #p < 0.05, ##p < 0.01
compared with chronic EF-stressed group (one-way ANOVA followed by Tukey’s test); §p < 0.05 compared with between the un-stressed
groups and stressed groups (two-way ANOVA followed by Tukey’s test)
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with those by GP-EX as a positive control [6], in order to
investigate whether GPS was the main functional compo-
nents for anxiety disorders.
The anxiety behavior in the elevated plus-maze test is
expressed as a passive avoidance in response to a poten-
tial threat. In contrast, the defensive burying behavior in
the marble burying test represents an active coping
strategy in response to a discrete threat [20]. In addition,
spontaneous locomotor activity is reduced in response
to anxiety disorders and sedation [9].
GPS (100–400 mg/kg) has beneficial effects on mouse
model of PD [12, 13]. Therefore, GPS at the ranges of
30–400 mg/kg was selected to examine the ameliorating
effects on chronic stress-induced anxiety disorders in
mice. In our study, treatment with GPS at 100–200 mg/kg
significantly recovered chronic EF stress-reduced the
number of open arm entries and the time spent on open
arms (Fig. 1a and b). Closed arm entries, which are a
measure of motor activity in elevated plus-maze, were
slightly decreased by GPS, but it was not significant (data
not shown). The ratios of the number of open arm entries
to the total arm entries, which is considered to be related
to the level of anxiety, were significantly reduced in the
chronic EF-stressed groups. GPS (100–400 mg/kg) re-
duced the number of marbles buried which was increased
by chronic EF stress (Fig. 2). In addition, the spontaneouse
locomotor activity is related to dopamine levels [21]. At
early periods of 2–3 days, the locomotor activities of con-
trol group were increased by acute stress, which was
caused by increasing dopamine levels [22]. However, at
later periods of 6–10 days, anxiety and/or depression were
induced by the repeated chronic stress, and in these states,
the spontaneous locomotor activities were gradually de-
creased below than control group [6]. In this study, GPS
(100–200 mg/kg) reversed spontaneous locomotor activity
for day-6 to day-10. GPS also showed the significant pro-
tective effects between the un-stressed groups and
stressed groups at day-10, compared with day-1. These
results indicate that GPS shows the anxiolytic functions
without decreasing spontaneous locomotor activity in
mice. In addition, treatment with GP-WX (50 mg/kg)
exhibited an ameliorating effect on chronic EF stress-
induced anxiety disorders which was respectively measured
by elevated plus-maze, marble burying and locomotor
activity (Figs. 1, 2 and 3).
Chronic stress-induced anxiety disorders decreases dopa-
mine and serotonin levels in the brain [2]. Chronic stress-
induced anxiety-like states maintains the increased levels of
corticosterone compared with the un-stressed states. How-
ever, the levels of corticosterone induced by chronic stress
are lower than those by acute stressed states and these re-
duced levels of corticosterone lead to regulate dopamine
and serotonin levels [2]. In addition, anxiolytic-like beha-
vioral responses in the elevated plus-maze test are
mediated by the serotonin receptor functions [5]. The
number of marbles buried is reduced by benzodiazepine re-
ceptor agonist (diazepam) and serotonin reuptake inhibitor
(fluvoxamine) [6]. Dopamine receptor blocking agents in-
hibit spontaneous locomotor activity [21]. In this study,
dopamine and serotonin levels were reduced by chronic EF
stress in the brain, and they were increased by treatment
with GPS (100–200 mg/kg) (Table 1). In contrast, the
serum levels of corticosterone obviously increased by
chronic EF stress, and they were also reversed by treatment
with GPS (100–200 mg/kg) (Table 1). These results suggest
that GPS can effectively ameliorate chronic stress-induced
anxiety disorders by modulating the levels of dopamine,
serotonin and corticosterone. In addition, the same patterns
were also obtained by treatment with GP-WX (50 mg/kg)
(Table 1). The serum levels of corticosterone induced by
chronic EF stress were also modulated by treatment with
GP-WX (50 mg/kg) (Table 1).
Among the Fos family members, FosB levels increase
after being exposed to chronic stress [23], and the c-Fos
expression in the PVN regions increases by chronic and
acute stress in mice and rats [3, 4]. In addition, the PVN
is essential for regulation of the HPA axis and may
influence HPA axis hormone secretion such as cortico-
sterone [24, 25]. GPS (30–400 mg/kg) significantly reduced
c-Fos expression induced by chronic EF stress (Fig. 4), and
also reduced the serum levels of corticosterone (Table 1).
These results suggest that the modulation of c-Fos expres-
sion by GPS plays a role in the protective function in anx-
iety disorders induced by chronic EF stress. Chronic EF
stress-induced c-Fos expression also decreased by GP-WX
(50 mg/kg) in the PVN regions (Fig. 4).
In this study, GPS (30 and 50 mg/kg) exhibited the trend
of anxiolytic effects on chronic EF stress-induced anxiety
disorders, but it was not significant. GPS (400 mg/kg)
also showed the anxiolytic effects on chronic EF stress-
induced anxiety disorders. However, GPS at the ranges
of 100–200 mg/kg showed a maximal efficacy on anxiolytic
functions, as compared with GPS (30, 50 and 400 mg/kg).
The high dose of GPS (400 mg/kg) might not be adopted
for an oral administration in mice and the similar results
have been also observed in a previous study [13].
GPS has been found to protect aortic endothelial cells
against oxidative damage [26]. GPS shows the protective
effects on oxidative stress induced by glutamate-induced
neurotoxicity [27]. In addition, oxidative stress may cause
the anxiety-related behaviors and the antioxidants could be
used for the prevention or reduction of the high anxiety
[28]. It is therefore possible to explain that the symptoms
of anxiety disorders induced by chronic EF stress can be re-
lieved by treatment with GPS and GP-WX, which has been
closely mediated by the anti-oxidative activity in rodents.
In the present study, GPS at 100–200 mg/kg, but
not 50 mg/kg, showed an equivalent efficacy on the
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anxiety behavioral tests, as compared with GP-EX at
50 mg/kg. However, GP-WX (50 mg/kg) showed a slightly
less effect on the chronic stress-induced anxiety disorders
than GP-EX (50 mg/kg) and GPS (100–200 mg/kg). GP-
WX or GP-EX has been identified to have many kinds of
GPS, flavonoids, polysaccharides, vitamins and amino
acids [10]. GPS, GP-WX and GP-EX showed the different
chromatogram patterns by the levels of bioactive compo-
nents (the supplement data): GP-EX contained mainly the
gypenoside, flavonoid and polysaccharide components,
and GP-WX also contained the polysaccharide compo-
nents. The levels of gypenoside components in GPS were
higher than those in GP-EX. In addition, the levels of
polysaccharide components in GP-EX were higher than
those in GP-WX, which was much higher than those in
GPS. The polysaccharides of GP-EX show various
functions, including anti-aging, anti-fatigue, improving-
immune competence and potential anti-oxidant [29, 30].
Polysaccharides supplementation also has beneficial
effects on attenuating the oxidative stress induced by
exhaustive exercise in rats [31]. These results suggest that
GPS plays an important role in anti-anxiety disorders, and
that besides GPS, the bioactive components including
flavonoids and polysaccharides in GP-EX or GP-WX also
show the anxiolytic-like functions. However, the intensities
of anxiolytic-like functions between GPS and polysaccha-
rides from GP need to be studied.
GPS (50–400 mg/kg) for 10 days does not exhibit the
adverse effects, such as weight loss, diarrhea, vomiting and
death. The values of LD50 of total GPS are 755–838 mg/kg
(injected into the abdominal cavity) and 402 mg/kg
(±18.2 mg/kg, i.p.) in mice [32]. GP-WX (750 mg/kg)
does not also produce any significant toxicity in rats dur-
ing 6-month period of treatment [33]. The lethal dose of
total GP-EX is 1800–2000 mg/kg (p.o.) (data not shown).
These results suggest that GPS might be safe more than
GP-EX although GPS shows a less efficacy on chronic
stress-induced anxiety disorders than GP-EX. However,
GPS, GP-WX and GP-EX have been proved as safe herbal
materials for treatment with animal models [6, 10].
Conclusion
GPS (100–200 mg/kg) exhibited the anxiolytic effects on
chronic EF stress-induced anxiety behaviors in mice,
which was evaluated by the elevated plus-maze and mar-
ble burying and spontaneous locomotor activity tests by
modulating the levels of dopamine, serotonin, cortico-
sterone and c-Fos expression. GP-WX also showed the
anxiolytic activity on chronic EF stress-induced anxiety
behaviors in mice, but it was lower activities than those
obtained by GPS. GPS may serve as a phytonutrient in
chronic stress-induced anxiety disorders and clinical
tests of GPS need to be conducted further.
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